Expanded investigation into pathways implicated in endostatin activity and vessel co-option such as WNT/beta catenin and integrin signaling, may shed further light onto the effects of lymphoma motility, migration, and vessel co-option that we observed. This evidence concerns the gene COL18A1 and lymphoma.